Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 35

1.

Moderately elevated first trimester fasting plasma total homocysteine is associated with increased probability of miscarriage. The Reus-Tarragona Birth Cohort Study.

Cavallé-Busquets P, Inglès-Puig M, Fernandez-Ballart JD, Haro-Barceló J, Rojas-Gómez A, Ramos-Rodriguez C, Ballesteros M, Meyer K, Ueland PM, Murphy MM.

Biochimie. 2020 Jan 18. pii: S0300-9084(20)30010-9. doi: 10.1016/j.biochi.2020.01.008. [Epub ahead of print]

PMID:
31962182
2.

Gestational diabetes impacts fetal precursor cell responses with potential consequences for offspring.

Algaba-Chueca F, Maymó-Masip E, Ejarque M, Ballesteros M, Llauradó G, López C, Guarque A, Serena C, Martínez-Guasch L, Gutiérrez C, Bosch R, Vendrell J, Megía A, Fernández-Veledo S.

Stem Cells Transl Med. 2020 Mar;9(3):351-363. doi: 10.1002/sctm.19-0242. Epub 2019 Dec 27.

3.

Extending the RIGHT statement for reporting adapted practice guidelines in healthcare: the RIGHT-Ad@pt Checklist protocol.

Song Y, Darzi A, Ballesteros M, Martínez García L, Alonso-Coello P, Arayssi T, Bhaumik S, Chen Y, Cluzeau F, Ghersi D, Padilla PF, Langlois EV, Schünemann HJ, Vernooij RWM, Akl EA.

BMJ Open. 2019 Sep 24;9(9):e031767. doi: 10.1136/bmjopen-2019-031767.

4.

Next-Generation Sequencing Improves Diagnosis, Prognosis and Clinical Management of Myeloid Neoplasms.

Carbonell D, Suárez-González J, Chicano M, Andrés-Zayas C, Triviño JC, Rodríguez-Macías G, Bastos-Oreiro M, Font P, Ballesteros M, Muñiz P, Balsalobre P, Kwon M, Anguita J, Díez-Martín JL, Buño I, Martínez-Laperche C.

Cancers (Basel). 2019 Sep 13;11(9). pii: E1364. doi: 10.3390/cancers11091364.

5.

The effect of prenatal smoke exposure on child neuropsychological function: a prospective mother-child cohort study.

Roigé-Castellví J, Murphy M, Hernández-Martínez C, Solé-Navais P, Cavallé-Busquets P, Fernández-Ballart J, Ballesteros M, Canals J.

J Reprod Infant Psychol. 2020 Feb;38(1):25-37. doi: 10.1080/02646838.2019.1580350. Epub 2019 Feb 19.

PMID:
30777448
6.

Healthcare professionals' opinions, barriers and facilitators towards low-value clinical practices in the hospital setting.

Osorio D, Ribera A, Solans-Domènech M, Arroyo-Moliner L, Ballesteros M, Romea-Lecumberri S.

Gac Sanit. 2019 Feb 10. pii: S0213-9111(19)30006-8. doi: 10.1016/j.gaceta.2018.11.007. [Epub ahead of print]

7.

Evidence mapping and quality assessment of systematic reviews on therapeutic interventions for oral cancer.

Madera Anaya M, Franco JVA, Ballesteros M, Solà I, Urrútia Cuchí G, Bonfill Cosp X.

Cancer Manag Res. 2018 Dec 24;11:117-130. doi: 10.2147/CMAR.S186700. eCollection 2019.

8.

Subcutaneous bortezomib in newly diagnosed patients with multiple myeloma nontransplant eligible: Retrospective evaluation.

de Arriba de la Fuente F, Durán MS, Álvarez MÁ, Sanromán IL, Dios AM, Ríos Tamayo R, García R, González MS, Prieto E, Bárez A, Escalante F, Tejedor A, Ballesteros M, Cabañas V, Capote FJ, Couto C, Garzón S, González-Pardo M, Mateos Manteca MV.

Semin Hematol. 2018 Oct;55(4):189-196. doi: 10.1053/j.seminhematol.2017.09.002. Epub 2017 Oct 13. Review.

PMID:
30502846
9.

Early pregnancy folate-cobalamin interactions and their effects on cobalamin status and hematologic variables throughout pregnancy.

Solé-Navais P, Salat-Batlle J, Cavallé-Busquets P, Fernandez-Ballart J, Ueland PM, Ballesteros M, Ornosa-Martín G, Inglès-Puig M, Colomina JM, Murphy MM.

Am J Clin Nutr. 2018 Feb 1;107(2):173-182. doi: 10.1093/ajcn/nqx041.

PMID:
29529156
10.

Evidence mapping based on systematic reviews of therapeutic interventions for gastrointestinal stromal tumors (GIST).

Ballesteros M, Montero N, López-Pousa A, Urrútia G, Solà I, Rada G, Pardo-Hernandez H, Bonfill X.

BMC Med Res Methodol. 2017 Sep 7;17(1):135. doi: 10.1186/s12874-017-0402-9.

11.

Development of a prioritisation tool for the updating of clinical guideline questions: the UpPriority Tool protocol.

Martínez García L, Pardo-Hernandez H, Niño de Guzman E, Superchi C, Ballesteros M, McFarlane E, Penman K, Posso M, Roqué I Figuls M, Sanabria AJ, Selva A, Vernooij RW, Alonso-Coello P.

BMJ Open. 2017 Aug 3;7(8):e017226. doi: 10.1136/bmjopen-2017-017226.

12.

Methodological systematic review identifies major limitations in prioritization processes for updating.

Martínez García L, Pardo-Hernandez H, Superchi C, Niño de Guzman E, Ballesteros M, Ibargoyen Roteta N, McFarlane E, Posso M, Roqué I Figuls M, Rotaeche Del Campo R, Sanabria AJ, Selva A, Solà I, Vernooij RWM, Alonso-Coello P.

J Clin Epidemiol. 2017 Jun;86:11-24. doi: 10.1016/j.jclinepi.2017.05.008. Epub 2017 May 24. Review.

PMID:
28549931
13.

Maternal Folate Status and the BHMT c.716G>A Polymorphism Affect the Betaine Dimethylglycine Pathway during Pregnancy.

Colomina JM, Cavallé-Busquets P, Fernàndez-Roig S, Solé-Navais P, Fernandez-Ballart JD, Ballesteros M, Ueland PM, Meyer K, Murphy MM.

Nutrients. 2016 Oct 9;8(10). pii: E621.

14.

Angiopoietin-like protein 8 (ANGPTL8) in pregnancy: a brown adipose tissue-derived endocrine factor with a potential role in fetal growth.

Martinez-Perez B, Ejarque M, Gutierrez C, Nuñez-Roa C, Roche K, Vila-Bedmar R, Ballesteros M, Redondo-Angulo I, Planavila A, Villarroya F, Vendrell J, Fernández-Veledo S, Megía A.

Transl Res. 2016 Dec;178:1-12. doi: 10.1016/j.trsl.2016.06.012. Epub 2016 Jul 9.

PMID:
27469268
15.

The MUK five protocol: a phase II randomised, controlled, parallel group, multi-centre trial of carfilzomib, cyclophosphamide and dexamethasone (CCD) vs. cyclophosphamide, bortezomib (Velcade) and dexamethasone (CVD) for first relapse and primary refractory multiple myeloma.

Brown S, Hinsley S, Ballesteros M, Bourne S, McGarry P, Sherratt D, Flanagan L, Gregory W, Cavenagh J, Owen R, Williams C, Kaiser M, Low E, Yong K; Myeloma UK Clinical Trials Network.

BMC Hematol. 2016 May 17;16:14. doi: 10.1186/s12878-016-0053-9. eCollection 2016.

16.

Cancer randomized trials showed that dissemination bias is still a problem to be solved.

Urrútia G, Ballesteros M, Djulbegovic B, Gich I, Roqué M, Bonfill X.

J Clin Epidemiol. 2016 Sep;77:84-90. doi: 10.1016/j.jclinepi.2016.04.011. Epub 2016 May 7.

PMID:
27164275
17.

Health care of pregnant women with diabetes in Spain: Approach using a questionnaire.

Rubio JA, Ontañón M, Perea V, Megia A; Grupo Español de Diabetes y Embarazo.

Endocrinol Nutr. 2016 Mar;63(3):113-20. doi: 10.1016/j.endonu.2015.11.005. Epub 2016 Jan 7. English, Spanish.

PMID:
26775016
18.

Cord blood FGF21 in gestational diabetes and its relationship with postnatal growth.

Megia A, Gil-Lluis P, Näf S, Ceperuelo-Mallafré V, Gonzalez-Clemente JM, Llauradó G, Nuñez-Roa C, Roche K, Ballesteros M, Yañez RE, Fernández-Veledo S, Vendrell J.

Acta Diabetol. 2015 Aug;52(4):693-700. doi: 10.1007/s00592-014-0705-9. Epub 2015 Jan 22.

PMID:
25604041
19.

Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts.

Font P, Loscertales J, Soto C, Ricard P, Novas CM, Martín-Clavero E, López-Rubio M, Garcia-Alonso L, Callejas M, Bermejo A, Benavente C, Ballesteros M, Cedena T, Calbacho M, Urbina R, Villarrubia J, Gil S, Bellón JM, Diez-Martin JL, Villegas A.

Ann Hematol. 2015 Apr;94(4):565-73. doi: 10.1007/s00277-014-2252-4. Epub 2014 Nov 13.

PMID:
25387664
20.

Serum activin A and follistatin levels in gestational diabetes and the association of the Activin A-Follistatin system with anthropometric parameters in offspring.

Näf S, Escote X, Ballesteros M, Yañez RE, Simón-Muela I, Gil P, Albaiges G, Vendrell J, Megia A.

PLoS One. 2014 Apr 24;9(4):e92175. doi: 10.1371/journal.pone.0092175. eCollection 2014.

Supplemental Content

Loading ...
Support Center